Aranding, Arjay .

HRN: 26-38-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/13/2024
12/20/2024
IV
520mg
Q6h
PCAP-D
Waiting Final Action 
12/13/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/13/2024
12/20/2024
IV
98mg
Q24h
PCAP-D
Waiting Final Action 
12/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/16/2024
12/22/2024
IV
65mg
Q6
PCAP D
Waiting Final Action 
12/21/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
12/21/2024
12/28/2024
PO
1ml
QID
Mouth Ulcer
Waiting Final Action 
12/23/2024
FLUCONAZOLE 150MG (CAP)
12/23/2024
12/30/2024
PO
75mg Pptab
OD
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: